Search Within

Hani Hassoun

Formats
  1. Meeting Abstract (232)
  2. Journal Article (90)
  3. Research Letter (9)
  4. Correspondence (4)
  5. Book Section (2)
  6. Review (2)
Groups
  1. Center for Hematologic Malignancies (339)
  2. Department of Medicine (339)
  3. Hematologic Malignancies, Division of (339)
  4. Myeloma (339)
  5. Survivorship Research (253)
  6. Bone Marrow Transplant (241)

More Groups

People
  1. Heather Landau (224)
  2. Sergio Giralt (205)
  3. Alexander Lesokhin (202)
  4. David Chung (166)
  5. Neha Korde (166)
  6. Sham Mailankody (163)

More People

Years
  1. 2025 (7)
  2. 2024 (35)
  3. 2023 (37)
  4. 2022 (36)
  5. 2021 (21)
  6. 2020 (28)

More Years

Publications
  1. Blood (133)
  2. Clinical Lymphoma, Myeloma and Leukemia (51)
  3. Journal of Clinical Oncology (27)
  4. Biology of Blood and Marrow Transplantation (19)
  5. Leukemia and Lymphoma (14)
  6. American Journal of Hematology (10)

More Publications

Publishers
  1. American Society of Hematology (141)
  2. Elsevier Inc. (74)
  3. American Society of Clinical Oncology (27)
  4. Nature Publishing Group (24)
  5. Taylor & Francis Group (21)
  6. John Wiley & Sons, Inc. (10)

More Publishers

Results (339)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MALDI-TOF mass spectrometry in serum for the follow-up of newly diagnosed multiple myeloma patients treated with daratumumab-based combination therapy
    Meeting Abstract

    Eveillard, M.; Hultcrantz, M.; Lesokhin, A. M.; Mailankody, S.; Smith, E. L.; Hassoun, H.; Shah, U. A.; Lu, S. X.; Korde, N.; Landgren, O.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • First description of B cell maturation antigen expression in light chain amyloidosis
    Meeting Abstract

    Bal, S.; Sigler, A.; Chan, A.; Chung, D. J.; Dogan, A.; Giralt, S. A.; Hassoun, H.; Landau, H. J.
    Blood (2019)

    Fulltext@MSK | Save
  • Long term outcomes of high dose therapy and autologous hematopoietic cell transplant for lymphoplasmacytic lymphoma-associated systemic amyloidosis
    Meeting Abstract

    Bal, S.; Shah, G. L.; Hassoun, H.; Palomba, M. L.; Giralt, S. A.; Landau, H.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Stem cell mobilization and autograft purity with novel induction regimens in multiple myeloma
    Meeting Abstract

    Bal, S.; Landau, H.; Shah, G. L.; Scordo, M.; Dahi, P. B.; Hassoun, H.; Hultcrantz, M.; Korde, N. S.; Lesokhin, A. M.; Lendvai, N.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Weekly carfilzomib, lenalidomide, dexamethasone and daratumumab (wKRd-D) combination therapy provides unprecedented MRD negativity rates in newly diagnosed multiple myeloma: A clinical and correlative phase 2 study
    Meeting Abstract

    Landgren, O.; Hultcrantz, M.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Smith, E. L.; Shah, U. A.; Lu, S. X.; Mastey, D.; Salcedo, M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • BCMA expression in AL Amyloidosis
    Meeting Abstract

    Bal, S.; Sigler, A.; Chan, A.; Chung, D.; Dogan, A.; Giralt, S.; Hassoun, H.; Landau, H.
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • A phase 1/2 study to assess safety and dose of ixazomib in combination with cyclophosphamide and dexamethasone in newly diagnosed patients with light chain (AL) amyloidosis
    Meeting Abstract

    Sanchez, L.; Landau, H.; Rosenbaum, C.; Abrahams, A.; Chin, C.; Liotta, B.; Agudo, N.; Ramnath, S.; Hoover, E.; Rahman, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Activity of melflufen in RR MM patients with extramedullary disease in the phase 2 HORIZON study (OP-106): Promising results in a high-risk population
    Meeting Abstract

    Richardson, P. G.; Mateos, M. V.; Rodriguez-Otero, P.; Norkin, M.; Larocca, A.; Hassoun, H.; Alegre, A.; Paner, A.; Leleu, X.; Maisel, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Depth of response and outcomes by initial therapy prior to autologous hematopoietic stem cell transplantation for multiple myeloma
    Meeting Abstract

    Shah, G.; Chung, D.; Scordo, M.; Seier, K.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Lesokhin, A.; Mailankody, S.; Shah, U.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Practice patterns with focal progression on daratumumab therapy
    Meeting Abstract

    Bal, S.; Peterson, T.; Landau, H.; Chung, D.; Giralt, S.; Korde, N.; Mailankody, S.; Smith, E.; Shah, U.; Hultcrantz, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save